Xishan Chen

1.3k total citations
32 papers, 1.0k citations indexed

About

Xishan Chen is a scholar working on Molecular Biology, Oncology and Otorhinolaryngology. According to data from OpenAlex, Xishan Chen has authored 32 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Oncology and 5 papers in Otorhinolaryngology. Recurrent topics in Xishan Chen's work include RNA Interference and Gene Delivery (5 papers), Nanoparticle-Based Drug Delivery (5 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Xishan Chen is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), Nanoparticle-Based Drug Delivery (5 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Xishan Chen collaborates with scholars based in China, United States and Nigeria. Xishan Chen's co-authors include Weiyue Lu, Xiaoli Wei, Ying Man, Changyou Zhan, Renba Liang, Cao Xie, Xiaodong Zhu, Wuyuan Lu, Kai-Hua Chen and Yongchu Sun and has published in prestigious journals such as Scientific Reports, ACS Applied Materials & Interfaces and Journal of Controlled Release.

In The Last Decade

Xishan Chen

31 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xishan Chen China 18 601 266 211 202 96 32 1.0k
Paula Ofek Israel 18 661 1.1× 400 1.5× 224 1.1× 319 1.6× 98 1.0× 27 1.2k
Zexiong Guo China 9 958 1.6× 487 1.8× 344 1.6× 234 1.2× 77 0.8× 15 1.4k
Andrew Satterlee United States 13 628 1.0× 369 1.4× 200 0.9× 425 2.1× 161 1.7× 29 1.2k
Ann‐Marie Chacko United States 18 299 0.5× 256 1.0× 173 0.8× 221 1.1× 134 1.4× 47 1.0k
Tingting Lin China 12 467 0.8× 409 1.5× 206 1.0× 373 1.8× 151 1.6× 47 1.1k
Sebastian C.J. Steiniger United States 11 460 0.8× 258 1.0× 152 0.7× 173 0.9× 65 0.7× 12 804
Hushan Yuan United States 19 862 1.4× 124 0.5× 143 0.7× 278 1.4× 121 1.3× 46 1.5k
Valeria R. Caiolfa Italy 17 704 1.2× 109 0.4× 225 1.1× 134 0.7× 199 2.1× 41 1.2k
Lorena Simón‐Gracia Estonia 19 630 1.0× 380 1.4× 172 0.8× 322 1.6× 301 3.1× 36 1.2k
Michael Teifel Germany 15 602 1.0× 483 1.8× 222 1.1× 300 1.5× 89 0.9× 34 1.1k

Countries citing papers authored by Xishan Chen

Since Specialization
Citations

This map shows the geographic impact of Xishan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xishan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xishan Chen more than expected).

Fields of papers citing papers by Xishan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xishan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xishan Chen. The network helps show where Xishan Chen may publish in the future.

Co-authorship network of co-authors of Xishan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xishan Chen. A scholar is included among the top collaborators of Xishan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xishan Chen. Xishan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liao, Chongbing, Jin Yan, William D. Tolbert, et al.. (2025). A Dual-Specificity d-Peptide Antagonist of MDM2 and MDMX for Antitumor Immunotherapy. Journal of Medicinal Chemistry. 68(16). 16940–16957.
2.
Lu, Ying, Haixin Huang, Hui Yang, et al.. (2022). Maintenance therapy improves the survival outcomes of patients with metastatic nasopharyngeal carcinoma responding to first-line chemotherapy: a multicentre, randomized controlled clinical study. Journal of Cancer Research and Clinical Oncology. 149(8). 4327–4338. 5 indexed citations
3.
4.
Chen, Xishan, et al.. (2021). Prognostic Role of EGFR/p-EGFR in Patients With Nasopharyngeal Carcinoma: A Meta-Analysis. Frontiers in Oncology. 11. 697369–697369. 12 indexed citations
5.
Chen, Li, Kai-Hua Chen, Fangzhu Wan, et al.. (2020). VEGF knockdown enhances radiosensitivity of nasopharyngeal carcinoma by inhibiting autophagy through the activation of mTOR pathway. Scientific Reports. 10(1). 16328–16328. 24 indexed citations
6.
Chen, Xishan, Renba Liang, & Xiaodong Zhu. (2020). Anti-EGFR therapies in nasopharyngeal carcinoma. Biomedicine & Pharmacotherapy. 131. 110649–110649. 51 indexed citations
7.
Chen, Xishan, Renba Liang, Lin Huan, et al.. (2020). CD166 promotes cancer stem cell-like phenotype via the EGFR/ERK1/2 pathway in the nasopharyngeal carcinoma cell line CNE-2R. Life Sciences. 267. 118983–118983. 13 indexed citations
8.
Liang, Renba, Xishan Chen, Li Chen, et al.. (2019). STAT3 signaling in ovarian cancer: a potential therapeutic target. Journal of Cancer. 11(4). 837–848. 76 indexed citations
9.
10.
Ruan, Huitong, Zhilan Chai, Qing Shen, et al.. (2018). A novel peptide ligand RAP12 of LRP1 for glioma targeted drug delivery. Journal of Controlled Release. 279. 306–315. 67 indexed citations
11.
Tai, Lingyu, Chang Liu, Kuan Jiang, et al.. (2017). A novel penetratin-modified complex for noninvasive intraocular delivery of antisense oligonucleotides. International Journal of Pharmaceutics. 529(1-2). 347–356. 31 indexed citations
12.
Tai, Lingyu, Chang Liu, Kuan Jiang, et al.. (2017). Noninvasive delivery of oligonucleotide by penetratin-modified polyplexes to inhibit protein expression of intraocular tumor. Nanomedicine Nanotechnology Biology and Medicine. 13(6). 2091–2100. 23 indexed citations
13.
Chen, Xishan & Weiyue Lu. (2016). Functional Interrogation of the N-Terminal Lid of MDMX in p53 Binding <i>via</i> Native Chemical Ligation. Chemical and Pharmaceutical Bulletin. 64(7). 1004–1008. 4 indexed citations
14.
Chen, Xishan, Lingyu Tai, Jie Gao, et al.. (2015). A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation. Journal of Controlled Release. 218. 29–35. 51 indexed citations
15.
Wei, Xiaoli, Xishan Chen, Ying Man, & Weiyue Lu. (2014). Brain tumor-targeted drug delivery strategies. Acta Pharmaceutica Sinica B. 4(3). 193–201. 159 indexed citations
16.
Zhan, Changyou, Le Zhao, Xishan Chen, Weiyue Lu, & Wuyuan Lu. (2013). Total chemical synthesis of dengue 2 virus capsid protein via native chemical ligation: Role of the conserved salt-bridge. Bioorganic & Medicinal Chemistry. 21(12). 3443–3449. 7 indexed citations
17.
Li, Chong, Changyou Zhan, Le Zhao, et al.. (2013). Functional consequences of retro-inverso isomerization of a miniature protein inhibitor of the p53–MDM2 interaction. Bioorganic & Medicinal Chemistry. 21(14). 4045–4050. 30 indexed citations
18.
Wang, Lu, Jiefu Jin, Xishan Chen, et al.. (2012). A cyanine based fluorophore emitting both single photon near-infrared fluorescence and two-photon deep red fluorescence in aqueous solution. Organic & Biomolecular Chemistry. 10(28). 5366–5366. 20 indexed citations
19.
Li, Jin, Bing Gu, Qinggang Meng, et al.. (2011). The use of myristic acid as a ligand of polyethylenimine/DNA nanoparticles for targeted gene therapy of glioblastoma. Nanotechnology. 22(43). 435101–435101. 49 indexed citations
20.
Chen, Xishan, et al.. (2010). Imaging beyond the diagnosis: image-guided enzyme/prodrug cancer therapy. Acta Biochimica et Biophysica Sinica. 43(1). 4–12. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paula Ofek Breakdown of academic impact, for papers by Zexiong Guo Breakdown of academic impact, for papers by Andrew Satterlee Breakdown of academic impact, for papers by Ann‐Marie Chacko Breakdown of academic impact, for papers by Tingting Lin Breakdown of academic impact, for papers by Sebastian C.J. Steiniger Breakdown of academic impact, for papers by Hushan Yuan Breakdown of academic impact, for papers by Valeria R. Caiolfa Breakdown of academic impact, for papers by Lorena Simón‐Gracia Breakdown of academic impact, for papers by Michael Teifel
Rankless by CCL
2026